CSI Market
Sign In | Register

Inovio Pharmaceuticals Inc (INO) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access INO Annual Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Inovio Pharmaceuticals Inc finances operations and invests in assets.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent36.70
Short-term Investments, Total0.00
Cash & Short-term Investments36.00
Accounts receivable0.04
Other Current Assets0.00
Prepaid Expense And Other Assets Current6.09
Total Current Assets39.91
Equipment/Property/Plant Net1.89
Other Assets, Noncurrent4.71
Total Assets49.39
Liabilities
Accounts Payable and Accrued Liabilities, Current LI11.65
Derivative Liability, Current DE25.02
Other Liabilities, Current0.00
Total Current Liabilities39.92
Total Long-term Debt0.00
Other liabilities, Noncurrent8.34
OperatingLeaseLiabilityNoncurrent5.79
Accrued Clinical Trial Expense Current0.82
Operating Lease Liability Current2.91
Total Liabilities45.02
Stockholders' Equity
Common Stock Value0.08
Additional Paid In Capital Common Stock1,845.43
Retained Earnings / Accumulated Deficit-1,840.86
Accumulated Other Comprehensive Income-0.28
Defined Benefit Plan and Other25.02
Other Equity-0.28
Common Stockholder's Equity4.37
Total Stockholder's Equity4.37
Liabilities & Stockholder's Equity49.39
4 historic quarters locked

Sign in to unlock the full Inovio Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Inovio Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 12, 2026
  • Source: ino-20260630.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001055726-26-000023

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.